• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Cancer Detection Test Fails in Major Study

The New York Times – Business:

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Cancer, Clinical Trials, DNA (Deoxyribonucleic Acid), Food and Drug Administration, Grail Inc, Health Insurance and Managed Care, Regulation and Deregulation of Industry, Research, Tests (Medical)
←Opendoor rises as JPMorgan boosts earnings estimates following Q4 results
Nvidia nears $30 billion investment in OpenAI’s funding round, the FT reports→

More posts

  • WATCH: Tornado rips through northwest Oklahoma amid severe storms across Plains

  • Think You Could Win “The Great British Bake Off”? Put Your Skills To The Test With This Cake Baking Simulator

  • The real problem with Hasan Piker

  • A.I. Start-Ups From Canada and Germany Merge to Take On Silicon Valley

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube